Expert insights. Personalized for you.
September 21, 2020–(BRONX, NY)–The first study comparing the immune responses of adults and children with COVID-19 has detected key differences that may contribute to understanding why children usually have milder disease than adults. MORE
Mid-range level of immune protein associated with lowest risk Philadelphia, November 10, 2020 – The causes of autism spectrum disorder (ASD) – including genetic and environmental factors – are not entirely understood. Many studies have already shown that serious maternal infection during pregnancy is associated with increased risk for offspring in both people and animals. […]. MORE
The addition of an anti-inflammatory medication to a common chemotherapy drug may improve immune response in patients by activating cells to fight cancer Credit: Cedars-Sinai LOS ANGELES (EMBARGOED UNTIL DEC. MORE
BOSTON – Exercise training may slow tumor growth and improve outcomes for females with breast cancer – especially those treated with immunotherapy drugs – by stimulating naturally occurring immune mechanisms, researchers at Massachusetts General Hospital (MGH) and Harvard […]. Tumors grew more slowly and responded better to immunotherapy in mice that exercised compared with sedentary mice. MORE
Greenwich LifeSciences Reports Robust Immune Response Phase IIb Data Supporting GP2 Clinical Outcome of 0% Metastatic Breast Cancer Recurrences Over 5 Years of Follow-up Greenwich LifeSciences Reports Robust Immune Response Phase IIb Data Supporting GP2 Clinical Outcome of 0% Metastatic … Continue reading → Business Wire MORE
MeMed CEO Dr. Eran Eden explores the relationship between the host immune response and SARS-CoV-2 infection and how technology could help personalise treatment strategies. One of these involves listening to what the body’s own immune system can tell us. MORE
The COVID-19 vaccine candidate developed by Sanofi and GlaxoSmithKline hit a snag that will delay the launch of a Phase III study due to an insufficient immune response in older trial patients MORE
A study of immune cells circulating in the blood hints the gut’s immune response to COVID-19 infection may not provide sufficient whole-body immunity from the virus Our guts may not provide long-lasting systemic immunity from COVID-19, which is where immune cells circulate through the body to provide protection to other organs, finds a new study […]. MORE
Early life exposure to antibotics in utero and through mother’s milk disrupts beneficial gut bacteria, compromising T-cell development, Rutgers research shows Exposure to antibiotics in utero and infancy can lead to an irreversible loss of regulatory T-cells in the colon-a valuable component of the immune system’s response toward allergens in later life – after only […]. MORE
Their work emphasizes how dependent the future course of the pandemic is on the nature of the adaptive immune response to this virus and on […]. Researchers who adapted standard epidemiological models to explore how the COVID-19 pandemic trajectory might unfold in the next five years report diverse scenarios ranging from recurring severe epidemics to elimination. MORE
The findings provide direction for future vaccines or therapies that may offer broader protection against variants LA JOLLA, CA–Fast-spreading variants of the COVID-19-causing coronavirus, SARS-CoV-2, carry mutations that enable the virus to escape some of the immune response created naturally or by vaccination. MORE
In doing so, a WVU researcher has found it could protect men from stomach inflammation Credit: WVU Photo/Brian Persinger Autoimmune diseases have something in common with horses, bachelor’s degrees and daily flossing habits: women are more likely to have them. MORE
Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Moderna’s COVID-19 vaccine spurs immune response in older adults.Moderna’s COVID-19 vaccine spurs immune response in older adults ntaylor Wed, 09/30/2020 – 06:26 from FierceBiotech: Biotech [link]. MORE
14, 2021) – Researchers at Baylor College of Medicine have discovered how therapeutics targeting RNA splicing can activate antiviral immune pathways in triple negative breast cancers (TNBC) to trigger tumor cell death and signal the body’s immune response. HOUSTON – (Jan. MORE
Newly announced results of a Phase I dose-escalation study show CureVac’s COVID-19 vaccine candidate, CVnCoV, generates noticeable immune responses in healthy volunteers MORE
A single-dose intranasal influenza vaccine is safe and produces a durable immune response, according to a Phase 1 study published in the Journal of Clinical Investigation this week. MORE
(Boston)–Researchers from Boston University School of Medicine (BUSM) report the formation of human cells containing a green fluorescent protein or GFP (one of the most important proteins in biology and fluorescence imaging) genetically fused with two interferon stimulated genes (ISGs), namely Viperin and ISG15. This new creation makes these cells highly valuable reagents for reporting […]. Medicine & Health Medicine/Health MORE
Theratechnologies Announces New Data Demonstrating Tesamorelin’s Positive Effect on Immune Response Linked to Liver Inflammation Theratechnologies Announces New Data Demonstrating Tesamorelin’s Positive Effect on Immune Response Linked to Liver Inflammation Data presented at ENDO 2021 MONTREAL, March 20, 2021 (GLOBE … Continue reading → GlobeNewswire MORE
They believe that by inhibiting factor D, it would reduce the inflammatory reactions that make COVID-19 so deadly MORE
AstraZeneca’s COVID-19 vaccine candidate, AZD1222, currently being evaluated in phase 3 global trials, delivers a strong immune response, according to a new UK study. MORE
Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: COVID-flu combo vaccine from Novavax sparks immune response to both viruses in animals.COVID-flu combo vaccine from Novavax sparks immune response to both viruses in animals arlene.weintraub Mon, … Continue reading → #news MORE
?The new data shows REGEN-COV reduced the risk of death in hospitalized patients unable to mount their own immune response by 20 MORE
Cell Stem Cell, 2021, HOUSTON, TX – March 25, 2021 – Humans are born with tens of thousands of hematopoietic stem cells (HSCs) that collectively ensure lifelong production of blood and immune cells that protect us from infections. Credit: Hormaechea-Agulla et al., MORE
An initial look at the vaccine's effects on the elderly shows those in their 70s had similar responses to those under 55, Moderna told a government panel MORE
Immune cells specialize to ensure the most efficient defense against viruses and other pathogens. Researchers at the University of Basel have shed light on this specialization of T cells and shown that it occurs differently in the context of an acute and a chronic infection. This could be relevant for new approaches against chronic viral […]. Biology Immunology/Allergies/Asthma Medicine/Health Molecular Biology Virology MORE
Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: GSK sees ‘robust immune response’ from RSV vaccine hopefuls.GSK sees ‘robust immune response’ from RSV vaccine hopefuls badams Wed, 10/21/2020 – 04:07 from FierceBiotech: Biotech [link]. MORE
COVID-19 mRNA vaccines are âhighly effectiveâ in producing antibodies against SARS-CoV-2 in pregnant and lactating women; and also confer protective immunity to newborns, according to a new study. MORE
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones MORE
Credit: (C) Erica Tandori Researchers within the Biomedicine Discovery Institute at Monash University have made a breakthrough in understanding the role played by high-risk immune genes associated with the development of rheumatoid arthritis (RA). MORE
FDA greenlit the restart of AstraZeneca’s Phase III COVID-19 vaccine trial, the company said the preventative medication boosts immune responses in older and younger adults against the novel coronavirus Days after the U.S. MORE
Whether flu or coronavirus, it can take several days for the body to ramp up an effective response to a viral infection. New research appearing in the journal Nature Immunology describes how different cells in the immune system work together, communicate, and – in the case of cells called neutrophils – bring about their own […]. MORE
Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Insights into how COVID outsmarts the gut’s immune response could point to new treatments.Insights into how COVID outsmarts the gut’s immune response could point to new treatments … Continue reading → #news MORE
A University of Birmingham-led study funded by the UK Coronavirus Immunology Consortium has found that many patients with COVID-19 produce immune responses against their body’s own tissues or organs. COVID-19 has been associated with a variety of unexpected symptoms, both at the time of infection and for many months afterwards. It is not fully understand […]. Infectious Emerging Diseases Immunology/Allergies/Asthma Infectious/Emerging Diseases Medicine/Health MORE
Canadian study investigates immune response and vaccine hesitancy among Canada’s South Asian communities Canadian study investigates immune response and vaccine hesitancy among Canada’s South Asian communities HAMILTON, Ontario, June 03, 2021 (GLOBE NEWSWIRE) — The Government of Canada, through its … Continue reading → GlobeNewswire MORE
Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: CureVac links COVID-19 vaccine to immune response, setting it up to enter pivotal trial.CureVac links COVID-19 vaccine to immune response, setting it up to enter pivotal trial … Continue reading → #news MORE
response in the over-50s, the age group deemed at higher risk for contracting the severe form of the virus. . The interim results from the phase 2 trial on the vaccine, published today, on the contrary, showed a “ strong neutralizing antibody response” ? MORE
Sanofi and GSK announced today that their COVID-19 vaccine candidate demonstrated strong immune responses across all adult age groups in a Phase 2 trial. MORE
AstraZeneca’s COVID-19 vaccine candidate, AZD1222, elicited immune responses in older coronavirus patients similar to ones generated in younger adults, lending more promise to a vaccine that’s seen as one of the leading contenders in the race to become the first approved COVID-19 vaccine. MORE
Results suggest lasting immunity after infection In a promising result for the success of vaccines against COVID-19, rhesus macaque monkeys infected with the human coronavirus SARS-CoV-2 developed protective immune responses that might be reproduced with a vaccine. MORE
Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: China’s Sinovac sees speedy immune response with COVID-19 shot in early trials.China’s Sinovac sees speedy immune response with COVID-19 shot in early trials badams Wed, 11/18/2020 – … Continue reading → #news MORE
Immune Response Related Topics Bio Pharma Dive
AUGUST 26, 2020
An initial look at the vaccine's effects on the elderly shows those in their 70s had similar responses to those under 55, Moderna told a government panel
Pharma Phorum
MARCH 15, 2021
MeMed CEO Dr. Eran Eden explores the relationship between the host immune response and SARS-CoV-2 infection and how technology could help personalise treatment strategies. One of these involves listening to what the body’s own immune system can tell us.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Scienmag
DECEMBER 7, 2020
The addition of an anti-inflammatory medication to a common chemotherapy drug may improve immune response in patients by activating cells to fight cancer Credit: Cedars-Sinai LOS ANGELES (EMBARGOED UNTIL DEC.
Scienmag
APRIL 16, 2021
Credit: (C) Erica Tandori Researchers within the Biomedicine Discovery Institute at Monash University have made a breakthrough in understanding the role played by high-risk immune genes associated with the development of rheumatoid arthritis (RA).
BioSpace
JUNE 15, 2021
?The new data shows REGEN-COV reduced the risk of death in hospitalized patients unable to mount their own immune response by 20
BioSpace
OCTOBER 25, 2020
FDA greenlit the restart of AstraZeneca’s Phase III COVID-19 vaccine trial, the company said the preventative medication boosts immune responses in older and younger adults against the novel coronavirus Days after the U.S.
BioTech 365
JUNE 3, 2021
Canadian study investigates immune response and vaccine hesitancy among Canada’s South Asian communities Canadian study investigates immune response and vaccine hesitancy among Canada’s South Asian communities HAMILTON, Ontario, June 03, 2021 (GLOBE NEWSWIRE) — The Government of Canada, through its … Continue reading → GlobeNewswire
Scienmag
JANUARY 14, 2021
14, 2021) – Researchers at Baylor College of Medicine have discovered how therapeutics targeting RNA splicing can activate antiviral immune pathways in triple negative breast cancers (TNBC) to trigger tumor cell death and signal the body’s immune response. HOUSTON – (Jan.
BioSpace
DECEMBER 10, 2020
The COVID-19 vaccine candidate developed by Sanofi and GlaxoSmithKline hit a snag that will delay the launch of a Phase III study due to an insufficient immune response in older trial patients
Scienmag
APRIL 12, 2021
BOSTON – Exercise training may slow tumor growth and improve outcomes for females with breast cancer – especially those treated with immunotherapy drugs – by stimulating naturally occurring immune mechanisms, researchers at Massachusetts General Hospital (MGH) and Harvard […]. Tumors grew more slowly and responded better to immunotherapy in mice that exercised compared with sedentary mice.
The Pharma Data
MAY 17, 2021
response in the over-50s, the age group deemed at higher risk for contracting the severe form of the virus. . The interim results from the phase 2 trial on the vaccine, published today, on the contrary, showed a “ strong neutralizing antibody response” ?
BioTech 365
FEBRUARY 10, 2021
Scienmag
MAY 20, 2021
The findings provide direction for future vaccines or therapies that may offer broader protection against variants LA JOLLA, CA–Fast-spreading variants of the COVID-19-causing coronavirus, SARS-CoV-2, carry mutations that enable the virus to escape some of the immune response created naturally or by vaccination.
BioTech 365
MAY 10, 2021
Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: COVID-flu combo vaccine from Novavax sparks immune response to both viruses in animals.COVID-flu combo vaccine from Novavax sparks immune response to both viruses in animals arlene.weintraub Mon, … Continue reading → #news
BioSpace
NOVEMBER 1, 2020
Newly announced results of a Phase I dose-escalation study show CureVac’s COVID-19 vaccine candidate, CVnCoV, generates noticeable immune responses in healthy volunteers
Scienmag
APRIL 1, 2021
Early life exposure to antibotics in utero and through mother’s milk disrupts beneficial gut bacteria, compromising T-cell development, Rutgers research shows Exposure to antibiotics in utero and infancy can lead to an irreversible loss of regulatory T-cells in the colon-a valuable component of the immune system’s response toward allergens in later life – after only […].
BioPharma Reporter
FEBRUARY 4, 2021
A single-dose intranasal influenza vaccine is safe and produces a durable immune response, according to a Phase 1 study published in the Journal of Clinical Investigation this week.
Scienmag
JUNE 3, 2021
A University of Birmingham-led study funded by the UK Coronavirus Immunology Consortium has found that many patients with COVID-19 produce immune responses against their body’s own tissues or organs. COVID-19 has been associated with a variety of unexpected symptoms, both at the time of infection and for many months afterwards. It is not fully understand […]. Infectious Emerging Diseases Immunology/Allergies/Asthma Infectious/Emerging Diseases Medicine/Health
BioPharma Reporter
MAY 17, 2021
Sanofi and GSK announced today that their COVID-19 vaccine candidate demonstrated strong immune responses across all adult age groups in a Phase 2 trial.
Scienmag
JANUARY 22, 2021
Results suggest lasting immunity after infection In a promising result for the success of vaccines against COVID-19, rhesus macaque monkeys infected with the human coronavirus SARS-CoV-2 developed protective immune responses that might be reproduced with a vaccine.
Scienmag
MAY 12, 2021
In doing so, a WVU researcher has found it could protect men from stomach inflammation Credit: WVU Photo/Brian Persinger Autoimmune diseases have something in common with horses, bachelor’s degrees and daily flossing habits: women are more likely to have them.
Scienmag
APRIL 19, 2021
A study of immune cells circulating in the blood hints the gut’s immune response to COVID-19 infection may not provide sufficient whole-body immunity from the virus Our guts may not provide long-lasting systemic immunity from COVID-19, which is where immune cells circulate through the body to provide protection to other organs, finds a new study […].
The Pharma Data
OCTOBER 22, 2020
AstraZeneca’s COVID-19 vaccine candidate, AZD1222, currently being evaluated in phase 3 global trials, delivers a strong immune response, according to a new UK study.
Scienmag
SEPTEMBER 21, 2020
September 21, 2020–(BRONX, NY)–The first study comparing the immune responses of adults and children with COVID-19 has detected key differences that may contribute to understanding why children usually have milder disease than adults.
BioTech 365
MARCH 20, 2021
Theratechnologies Announces New Data Demonstrating Tesamorelin’s Positive Effect on Immune Response Linked to Liver Inflammation Theratechnologies Announces New Data Demonstrating Tesamorelin’s Positive Effect on Immune Response Linked to Liver Inflammation Data presented at ENDO 2021 MONTREAL, March 20, 2021 (GLOBE … Continue reading → GlobeNewswire
BioSpace
OCTOBER 18, 2020
They believe that by inhibiting factor D, it would reduce the inflammatory reactions that make COVID-19 so deadly
BioSpace
MAY 20, 2021
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones
BioTech 365
APRIL 27, 2021
Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Insights into how COVID outsmarts the gut’s immune response could point to new treatments.Insights into how COVID outsmarts the gut’s immune response could point to new treatments … Continue reading → #news
The Pharma Data
OCTOBER 26, 2020
AstraZeneca’s COVID-19 vaccine candidate, AZD1222, elicited immune responses in older coronavirus patients similar to ones generated in younger adults, lending more promise to a vaccine that’s seen as one of the leading contenders in the race to become the first approved COVID-19 vaccine.
Scienmag
MARCH 25, 2021
Cell Stem Cell, 2021, HOUSTON, TX – March 25, 2021 – Humans are born with tens of thousands of hematopoietic stem cells (HSCs) that collectively ensure lifelong production of blood and immune cells that protect us from infections. Credit: Hormaechea-Agulla et al.,
BioTech 365
APRIL 9, 2021
Greenwich LifeSciences Reports Robust Immune Response Phase IIb Data Supporting GP2 Clinical Outcome of 0% Metastatic Breast Cancer Recurrences Over 5 Years of Follow-up Greenwich LifeSciences Reports Robust Immune Response Phase IIb Data Supporting GP2 Clinical Outcome of 0% Metastatic … Continue reading → Business Wire
BioPharma Reporter
MARCH 30, 2021
COVID-19 mRNA vaccines are âhighly effectiveâ in producing antibodies against SARS-CoV-2 in pregnant and lactating women; and also confer protective immunity to newborns, according to a new study.
Scienmag
MAY 18, 2021
(Boston)–Researchers from Boston University School of Medicine (BUSM) report the formation of human cells containing a green fluorescent protein or GFP (one of the most important proteins in biology and fluorescence imaging) genetically fused with two interferon stimulated genes (ISGs), namely Viperin and ISG15. This new creation makes these cells highly valuable reagents for reporting […]. Medicine & Health Medicine/Health
BioTech 365
NOVEMBER 18, 2020
Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: China’s Sinovac sees speedy immune response with COVID-19 shot in early trials.China’s Sinovac sees speedy immune response with COVID-19 shot in early trials badams Wed, 11/18/2020 – … Continue reading → #news
Scienmag
NOVEMBER 10, 2020
Mid-range level of immune protein associated with lowest risk Philadelphia, November 10, 2020 – The causes of autism spectrum disorder (ASD) – including genetic and environmental factors – are not entirely understood. Many studies have already shown that serious maternal infection during pregnancy is associated with increased risk for offspring in both people and animals. […].
BioTech 365
NOVEMBER 2, 2020
Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: CureVac links COVID-19 vaccine to immune response, setting it up to enter pivotal trial.CureVac links COVID-19 vaccine to immune response, setting it up to enter pivotal trial … Continue reading → #news
BioTech 365
OCTOBER 21, 2020
Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: GSK sees ‘robust immune response’ from RSV vaccine hopefuls.GSK sees ‘robust immune response’ from RSV vaccine hopefuls badams Wed, 10/21/2020 – 04:07 from FierceBiotech: Biotech [link].
Scienmag
SEPTEMBER 21, 2020
Their work emphasizes how dependent the future course of the pandemic is on the nature of the adaptive immune response to this virus and on […]. Researchers who adapted standard epidemiological models to explore how the COVID-19 pandemic trajectory might unfold in the next five years report diverse scenarios ranging from recurring severe epidemics to elimination.
Scienmag
OCTOBER 1, 2020
Whether flu or coronavirus, it can take several days for the body to ramp up an effective response to a viral infection. New research appearing in the journal Nature Immunology describes how different cells in the immune system work together, communicate, and – in the case of cells called neutrophils – bring about their own […].
BioTech 365
SEPTEMBER 30, 2020
Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Moderna’s COVID-19 vaccine spurs immune response in older adults.Moderna’s COVID-19 vaccine spurs immune response in older adults ntaylor Wed, 09/30/2020 – 06:26 from FierceBiotech: Biotech [link].
43 
Let's personalize your content